CIK 0001689548 · Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion | +164,832 | 7,594,109 | ||
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −7,375,799 | 0 | ||
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −5,052,852 | 0 | ||
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion · Series B-1 Redeemable Convertible Preferred Stock | −1,410,477 | 0 | ||
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion · Series C Redeemable Convertible Preferred Stock | −559,208 | 0 | ||
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion · Series C Redeemable Convertible Preferred Stock | −1,941,748 | 0 | ||
| 2020-10-20 | BSOF Parallel Master Fund L.P. 10% owner | Conversion · Series C-1 Redeemable Convertible Preferred Stock | −352,734 | 0 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion | +3,446,711 | 4,147,645 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion | +2,361,198 | 6,508,843 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion | +659,116 | 7,167,959 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion | +261,318 | 7,429,277 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion | +907,378 | 907,378 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion | +164,832 | 7,594,109 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −7,375,799 | 0 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −5,052,852 | 0 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion · Series B-1 Redeemable Convertible Preferred Stock | −1,410,477 | 0 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion · Series C Redeemable Convertible Preferred Stock | −559,208 | 0 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion · Series C Redeemable Convertible Preferred Stock | −1,941,748 | 0 | ||
| 2020-10-20 | Clarus Lifesciences III, L.P. 10% owner | Conversion · Series C-1 Redeemable Convertible Preferred Stock | −352,734 | 0 | ||
| 2020-10-20 | Novo Holdings A/S 10% owner | Conversion | +2,442,080 | 2,442,080 |
Page 16 of 17 · 331 trades